Related Experiment Video

Updated: May 14, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Current standards in diagnosis and therapy of hyperlipoproteinemia

S Fischer1, U Schatz, U Julius

  • 1Department of Internal Medicine III, University Hospital Dresden Carl Gustav Carus Dresden, Technical University Dresden, Fetscherstr 74, 01307 Dresden, Germany. sabine.fischer@uniklinikum-dresden.de

Atherosclerosis. Supplements
|January 30, 2013
PubMed

Insights

High cholesterol, particularly LDL-cholesterol and lipoprotein(a) (Lp(a)), significantly elevates atherosclerosis risk. Effective hyperlipoproteinemia therapy requires personalized approaches considering other health factors and includes lifestyle changes and various lipid-lowering medications.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Elevated lipid parameters, specifically LDL-cholesterol and lipoprotein(a) (Lp(a)), are critical risk factors for atherosclerosis development.
  • Hyperlipoproteinemia management is influenced by comorbidities like diabetes mellitus and existing cardiovascular disease.
  • Standard diagnostic measures include fasting lipid profiles (total cholesterol, LDL-C, HDL-C, triglycerides).

Purpose of the Study:

  • To outline the diagnostic criteria and therapeutic strategies for hyperlipoproteinemia.
  • To emphasize the importance of evaluating lipoprotein(a) in specific patient populations.
  • To describe management approaches for special hyperlipoproteinemia forms, including chylomicronemia syndrome and elevated Lp(a).

Main Methods:

  • Review of diagnostic parameters for hyperlipoproteinemia, including lipid profiles and Lp(a) assessment.
  • Discussion of non-pharmacological interventions: diet, weight reduction, and lifestyle modifications.
  • Overview of pharmacological treatments: statins, bile acid sequestrants, ezetimibe, fibrates, nicotinic acid, and omega-3 fatty acids.

Main Results:

  • Lipid levels, especially LDL-C and Lp(a), are key indicators for cardiovascular risk.
  • Therapeutic targets are individualized based on patient risk factors and existing conditions.
  • A combination of lifestyle changes and diverse drug classes forms the cornerstone of treatment.

Conclusions:

  • Comprehensive management of hyperlipoproteinemia involves accurate diagnosis, risk stratification, and tailored therapeutic interventions.
  • Lipoprotein(a) evaluation is crucial for identifying individuals at high risk for premature cardiovascular events.
  • Effective treatment strategies encompass lifestyle modifications and a range of lipid-lowering agents to mitigate atherosclerosis risk.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...